Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escalating permethrin therapy trial for scabies
2019-003234-16Phase 3Active
- Sponsor
- InfectoPharm
- Start
- Sep 2020
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of permethrin in scabies (4 arms), sponsored by InfectoPharm. Primary endpoint: Primary efficacy endpoint. Started Sep 2020; status: active.
02
Drugs
permethrin
03
Conditions
scabies
Beyond the preview
Go deeper on 2019-003234-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003234-16.